Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Chemomab Therapeutics Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +3 vs. Q2 2022
- Shares held
- 3.25M
- −35.6K (−1.1%) vs. Q2 2022
- Total value
- $8.09M
- −$4.06M (−33.4%) vs. Q2 2022
- New holders
- 4
- 2 more added
- Sold out
- 1
- 6 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $615.3K |
| Q1 2026 | 15 | $551.9K |
| Q4 2025 | 14 | $606.1K |
| Q3 2025 | 10 | $1.03M |
| Q2 2025 | 14 | $4.91M |
| Q1 2025 | 17 | $4.07M |
| Q4 2024 | 16 | $7.53M |
| Q3 2024 | 15 | $7.14M |
| Q2 2024 | 15 | $2.44M |
| Q1 2024 | 14 | $2.07M |
| Q4 2023 | 16 | $1.43M |
| Q3 2023 | 11 | $2.26M |
| Q2 2023 | 11 | $3.33M |
| Q1 2023 | 13 | $4.56M |
| Q4 2022 | 14 | $10.6M |
| Q3 2022 | 15 | $8.09M |
| Q2 2022 | 13 | $12.2M |
| Q1 2022 | 15 | $15.9M |
| Q4 2021 | 14 | $22.7M |
| Q3 2021 | 15 | $35.9M |
| Q2 2021 | 12 | $58.7M |
| Q1 2021 | 10 | $82.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Chemomab Therapeutics Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 2,578,174 | $6.42M | 0.13% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 288,169 | $718.0K | 0.05% | +10.0% | Added |
| Ikarian Capital, LLC | 245,896 | $612.0K | 0.31% | −22,208−8.3% | Reduced |
| Boothbay Fund Management, LLC | 37,371 | $93.0K | 0.00% | −3,929−9.5% | Reduced |
| State Street Corp | 28,640 | $71.0K | 0.00% | −7,545−20.9% | Reduced |
| Citadel Advisors LLC | 21,226 | $53.0K | 0.00% | +21,226 | New |
| Envestnet Asset Management Inc | 11,716 | $29.0K | 0.00% | −477−3.9% | Reduced |
| Geode Capital Management, LLC | 11,737 | $29.0K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 7,600 | $19.0K | 0.01% | +7,600 | New |
| Advisor Group Holdings, Inc. | 6,987 | $18.0K | 0.00% | −741−9.6% | Reduced |
| Morgan Stanley | 6,200 | $15.0K | 0.00% | +605+10.8% | Added |
| UBS Group AG | 4,888 | $12.0K | 0.00% | +4,888 | New |
| Newbridge Financial Services Group, Inc. | 1,100 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 246 | $1.00K | 0.00% | −2−0.8% | Reduced |
| Credit Suisse AG | 1 | $0 | 0.00% | +1 | New |
| Meitav Dash Investments Ltd | 0 | $0 | 0.00% | −35,024−100.0% | Sold out |
| Urban Wealth Management, LLC | – | – | – | – | Not filed |